Incidence, prevalence, and survival outcomes of patients with myeloproliferative neoplasms in the United States: a Surveillance, Epidemiology, and End Results (SEER) database analysis, years 2000-2021.

Singhal S, Mishra R, Arora S, Sharafeldin N, Desai R, Jain T, Vachhani P

Open source

DOI
10.1038/s41375-026-03124-9
Published
2026 Aug 31
Container
Leukemia
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41375-026-03124-9,
  title = {Incidence, prevalence, and survival outcomes of patients with myeloproliferative neoplasms in the United States: a Surveillance, Epidemiology, and End Results (SEER) database analysis, years 2000-2021.},
  author = {Singhal S and Mishra R and Arora S and Sharafeldin N and Desai R and Jain T and Vachhani P},
  year = {2026},
  journal = {Leukemia},
  doi = {10.1038/s41375-026-03124-9},
  url = {https://doi.org/10.1038/s41375-026-03124-9}
}

RIS

TY  - JOUR
TI  - Incidence, prevalence, and survival outcomes of patients with myeloproliferative neoplasms in the United States: a Surveillance, Epidemiology, and End Results (SEER) database analysis, years 2000-2021.
AU  - Singhal S
AU  - Mishra R
AU  - Arora S
AU  - Sharafeldin N
AU  - Desai R
AU  - Jain T
AU  - Vachhani P
PY  - 2026
JO  - Leukemia
DO  - 10.1038/s41375-026-03124-9
UR  - https://doi.org/10.1038/s41375-026-03124-9
ER  - 

APA

S, S., R, M., S, A., N, S., R, D., T, J., & P, V. (2026). Incidence, prevalence, and survival outcomes of patients with myeloproliferative neoplasms in the United States: a Surveillance, Epidemiology, and End Results (SEER) database analysis, years 2000-2021.. Leukemia. https://doi.org/10.1038/s41375-026-03124-9

Source records